Associated Papers
De novo variants in KDM2A cause a syndromic neurodevelopmental disorder.
Anderson EN et al.
American Journal of Human Genetics, 2026
41468891 (PubMed )
Supplement: mmc2.xlsx › S7_KDM_genes_literature
Phenotypical and Genotypical Expansion of Autosomal-Dominant KDM1A -Related Neurodevelopmental Disorder Spectrum: A Case Report.
Burkart S et al.
American Journal of Medical Genetics. Part A, 2025
O-GlcNAc transferase congenital disorder of glycosylation (OGT-CDG): Potential mechanistic targets revealed by evaluating the OGT interactome.
Mayfield JM et al.
The Journal of Biological Chemistry, 2024
De novo missense variants in HDAC3 leading to epigenetic machinery dysfunction are associated with a variable neurodevelopmental disorder.
Yoon JG et al.
American Journal of Human Genetics, 2024
Epigenetic Etiology of Intellectual Disability.
Iwase S et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience, 2017
Longitudinal analysis of treatment-induced genomic alterations in gliomas.
Erson-Omay EZ et al.
Genome Medicine, 2017
28153049 (PubMed )
Supplement: 13073_2017_401_MOESM3_ESM.xlsx › AllMutations_Clonality
Gene discovery for Mendelian conditions via social networking: de novo variants in KDM1A cause developmental delay and distinctive facial features.
Chong JX et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2016
LSD1/KDM1A mutations associated to a newly described form of intellectual disability impair demethylase activity and binding to transcription factors.
Pilotto S et al.
Human Molecular Genetics, 2016
Novel mutations target distinct subgroups of medulloblastoma.
Robinson G et al.
Nature, 2012
22722829 (PubMed )
Supplement: NIHMS374717-supplement-table_5.xlsx › Tier1
Select a paper to view details